ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 352122 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 352122; 2) Community: the network communities that were significantly associated with the response to NSC 352122; 3) Molecule: the relationships between components within communities and NSC 352122; 4) MDR: the compounds that were significantly associated with the NSC 352122.

NSC Compound Enrichment Correlation
NSC 748913 2,3-Dehydrosarcovagine D 0.0304779558345021 0.31384588
NSC 750332 4-(4-chlorophenyl)-1-3-[(E)-3-(3,4,5-trimethoxyphenyl)-2-propenoyl]phenyl-2,3-dihydro-1H-2-imidazolone 0.0304779558345021 0.39217617
NSC 750937 Null 0.0304779558345021 0.3352956
NSC 753221 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline 0.0304779558345021 0.43890213
NSC 764039 AZD-5363 0.0304779558345021 -0.069329726
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.0304779558345021 0.43158961
NSC 107124 Camptothecin Derivative 0.0306776553926119 0.37484723
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0306776553926119 0.49130746
NSC 18298 Null 0.0306776553926119 -0.018529254
NSC 282159 EN 589 0.0306776553926119 0.1931129
Total:67  Current:44    [First] [Prev] [Next] [Last]